Showing results (131-140 of 447) with videos related to

Sort By:
Pageof 45
Journal of Hematology & Oncology|January 21, 2017
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II studyRui-Hua Xu, Jin Li, Yuxian Bai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2010
Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in ChinaMiao-zhen Qiu, Rui-hua Xu, Dan-yun Ruan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2016
Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysisFei Zhang, Yun Wang, Zhi-Qiang Wang, et al.
Gastroenterology Report|December 20, 2021
Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancerDan-Yun Ruan, Yan-Xing Chen, Xiao-Li Wei, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 19, 2007
[Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells]Yan-Xia Shi, Xiao-Shi Zhang, Jian-Chuan Xia, et al.
Genome Medicine|April 29, 2022
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy responseZhen Zhang, Zi-Xian Wang, Yan-Xing Chen, et al.
Oncotarget|April 23, 2016
Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinomaFei Zhang, Peng Sun, Zhi-Qiang Wang, et al.
Frontiers in Oncology|March 17, 2020
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC PathwayDong-Dong Yang, Zhan-Hong Chen, Kai Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-AnalysisHao-Xiang Wu, Yi-Qian Pan, Ye He, et al.
Cancer|February 28, 2007
High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancersFeng Wang, Rui-Hua Xu, Bing Han, et al.
Pageof 45